Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
CytoSorb sales8.96M91.61%
Grant income796.77K8.14%
Other Sales24.73K0.25%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
All other countries18.05M49.67%
Germany12.96M35.67%
United States5.33M14.67%